Abstract:Background: Observational studies have indicated a potential correlation between glioblastoma and circulating inflammatory proteins. Further investigation is required to establish a causal relationship between these two factors. Methods: We performed a Mendelian randomization (MR) analysis using genome-wide association study (GWAS) summary of 91 circulating inflammation-related proteins (N = 14,824) to assess their causal impact on glioblastoma. The GWAS summary data for glioblastoma included 243 cases and 287,137 controls. The inverse variance weighted (IVW) method was used as the primary analytical method to assess causality. Four additional MR methods [simple mode, MR-Egger, weighted median, and weighted mode] were used to supplement the IVW results. Furthermore, several sensitivity analyses were performed to assess heterogeneity, horizontal pleiotropy, and stability. Reverse MR analysis was also performed. glioblastoma transcriptomic data from The Cancer Genome Atlas (TCGA) were analyzed to validate the findings obtained through MR, while pathway and functional enrichment analyses were conducted to predict the potential underlying mechanisms. Results: Our findings from employing the inverse variance weighted method in our forward MR analysis provide robust evidence supporting a potential association between glioblastoma and elevated levels of Cystatin D, as well as decreased levels of fibroblast growth factor 21 (FGF21) in the circulation. Moreover, our reverse MR analysis revealed that glioblastoma may contribute to increased concentrations of C-X-C motif chemokine 9 (CXCL9) and Interleukin-33 (IL-33) in the bloodstream. Transcriptomic analysis showed that FGF21 expression was inversely associated with the risk of developing glioblastoma, whereas an increased risk was linked to elevated levels of CXCL9 and IL-33. Pathway and functional enrichment analyses suggested that Cystatin D might exert its effects on glioblastoma through intracellular protein transport, whereas FGF21 might affect glioblastoma via glucose response mechanisms. Conclusion: These results indicate that FGF21 is a significant factor in glioblastoma susceptibility. Glioblastoma also affects the expression of inflammatory proteins such as C-X-C motif chemokine 9 and Interleukin-33, providing new insights into the mechanisms of glioblastoma genesis and clinical research.

Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

Discussion on the relationship between gut microbiota and glioma through Mendelian randomization test based on the brain gut axis

Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis

Explore genetic susceptibility association between viral infections and Guillain-Barré syndrome risk using two-sample Mendelian randomization

Inflammatory factors and risk of meningiomas: a bidirectional mendelian-randomization study

Testing for causality between systematically identified risk factors and glioma: a Mendelian randomization study

Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis

Association between gut microbiota and glioblastoma: a Mendelian randomization study

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Causal effects of immune cells in glioblastoma: a Bayesian Mendelian Randomization study

Causal relationship between inflammatory proteins and glioblastoma: a two-sample bi‐directional mendelian randomization study

Causal association between immune cells and esophageal cancer: a bidirectional two-sample Mendelian randomization study

Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study

Causal Relationship Between Type 2 Diabetes and Glioblastoma: Bidirectional Mendelian Randomization Analysis

Causality between COVID-19 and multiple myeloma: a two-sample Mendelian randomization study and Bayesian co-localization

Unveiling the Impact of Epstein-Barr Virus on the Risk of Prostate Cancer: A Mendelian Randomization Study

Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study

Causal relationships between gut microbiota and lymphoma: a bidirectional Mendelian randomization study

Association between gut microbiota and hepatocellular carcinoma and biliary tract cancer: A mendelian randomization study

Causal associations of COVID‐19 on neurosurgical diseases risk: a Mendelian randomization study